BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 26819517)

  • 1. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.
    Sukowati CH; El-Khobar KE; Ie SI; Anfuso B; Muljono DH; Tiribelli C
    World J Gastroenterol; 2016 Jan; 22(4):1497-512. PubMed ID: 26819517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma and the underlying mechanisms.
    Oyagbemi AA; Azeez OI; Saba AB
    Afr Health Sci; 2010 Mar; 10(1):93-8. PubMed ID: 20811532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do persistent infections with hepatitis C virus cause liver cancer?
    Mitchell JK; Lemon SM; McGivern DR
    Curr Opin Virol; 2015 Oct; 14():101-8. PubMed ID: 26426687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological pathways in viral hepatitis-induced hepato-cellular carcinoma.
    Xu L; Xu Y; Zhang F; Xu P; Wang L
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):64-72. PubMed ID: 38426692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis B in hepatocarcinogenesis.
    Park NH; Song IH; Chung YH
    Postgrad Med J; 2006 Aug; 82(970):507-15. PubMed ID: 16891440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of hepatitis B virus e protein and core protein in hepatocarcinogenesis].
    Lefeuvre C; Ducancelle A
    Virologie (Montrouge); 2023 Dec; 27(6):320-332. PubMed ID: 38239027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal and structural patterns of hepatitis B virus integrations in hepatocellular carcinoma.
    Ren H; Chen X; Wang J; Chen Y; Hafiz A; Xiao Q; Fu S; Madireddy A; Li WV; Shi X; Cao J
    J Med Virol; 2023 Oct; 95(10):e29187. PubMed ID: 37877809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis.
    Capasso M; Cossiga V; Guarino M; Ranieri L; Morisco F
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus genotypes in precision medicine of hepatitis B-related hepatocellular carcinoma: Where we are now.
    Sukowati CHC; Jayanti S; Turyadi T; Muljono DH; Tiribelli C
    World J Gastrointest Oncol; 2024 Apr; 16(4):1097-1103. PubMed ID: 38660644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Hepatitis B Virus Genetic Variation, Integration, and Lymphotropism in Antiviral Treatment and Oncogenesis.
    Lau KCK; Burak KW; Coffin CS
    Microorganisms; 2020 Sep; 8(10):. PubMed ID: 32987867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2dFDR: a new approach to confounder adjustment substantially increases detection power in omics association studies.
    Yi S; Zhang X; Yang L; Huang J; Liu Y; Wang C; Schaid DJ; Chen J
    Genome Biol; 2021 Jul; 22(1):208. PubMed ID: 34256818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms.
    Martin M; Herceg Z
    Genome Med; 2012 Jan; 4(1):8. PubMed ID: 22293089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis.
    Medvedev R; Ploen D; Hildt E
    Oxid Med Cell Longev; 2016; 2016():9012580. PubMed ID: 26955431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation for viral hepatitis in 2015.
    Ferrarese A; Zanetto A; Gambato M; Bortoluzzi I; Nadal E; Germani G; Senzolo M; Burra P; Russo FP
    World J Gastroenterol; 2016 Jan; 22(4):1570-81. PubMed ID: 26819523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma: Where are we?
    Mazzanti R; Arena U; Tassi R
    World J Exp Med; 2016 Feb; 6(1):21-36. PubMed ID: 26929917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The core of hepatitis C virus pathogenesis.
    Kao CC; Yi G; Huang HC
    Curr Opin Virol; 2016 Apr; 17():66-73. PubMed ID: 26851516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma and hepatitis B surface protein.
    Li YW; Yang FC; Lu HQ; Zhang JS
    World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus: A time for decisions. Who should be treated and when?
    Attar BM; Van Thiel DH
    World J Gastrointest Pharmacol Ther; 2016 Feb; 7(1):33-40. PubMed ID: 26855810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of HBV-induced hepatocellular carcinoma.
    Levrero M; Zucman-Rossi J
    J Hepatol; 2016 Apr; 64(1 Suppl):S84-S101. PubMed ID: 27084040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.
    Tornesello ML; Buonaguro L; Izzo F; Buonaguro FM
    Oncotarget; 2016 May; 7(18):25087-102. PubMed ID: 26943571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.